Results of a phase 2 trial of the monocyte-targeted histone deacetylase inhibitor tefinostat (CHR-2845) in chronic myelomonocytic leukemia (CMML) - the UK monocle study

Bibliographic Details
Main Authors:	Vyas, P, Hills, R, Knapper, S, Dennis, M, Drummond, M, Dillon, R, Pocock, C, Culligan, D, Wiseman, D, Zabkiewicz, J, Hodges, M, Cargo, C, Taylor, J, Upton, L, Wright, M, Bowen, D
Format:	Conference item
Published:	American Society of Hematology 2018

Similar Items